A Comprehensive Analysis of Pyroptosis-Related lncRNAs Signature Associated With Prognosis and Tumor Immune Microenvironment of Pancreatic Adenocarcinoma

被引:11
|
作者
Zhao, Kai [1 ]
Li, Xiangyu [1 ]
Shi, Yuanxin [1 ]
Lu, Yun [1 ]
Qiu, Peng [1 ]
Deng, Zhengdong [1 ]
Yao, Wei [2 ]
Wang, Jianming [1 ,3 ]
机构
[1] Huazhong Univ Sci & Technol, Affiliated Tongji Hosp, Tongji Med Coll, Dept Biliary & Pancreat Surg,Canc Res Ctr, Wuhan, Peoples R China
[2] Huazhong Univ Sci & Technol, Affiliated Tongji Hosp, Tongji Med Coll, Dept Oncol, Wuhan, Peoples R China
[3] Wuhan Univ Sci & Technol, Affiliated Tianyou Hosp, Wuhan, Peoples R China
基金
中国国家自然科学基金;
关键词
pancreatic adenocarcinoma; pyroptosis; lncRNAs; prognosis; tumor immune microenvironment; immunotherapy; CELL-DEATH; CANCER STATISTICS; PROMOTES; PATHWAY;
D O I
10.3389/fgene.2022.899496
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Globally, pancreatic adenocarcinoma (PAAD) is a common and highly devastating gastrointestinal malignancy that seriously threatens human health. Pyroptosis refers to an emerging form of programmed cell death that has been discovered in recent years, and studies have demonstrated that long non-coding RNA (lncRNA) may act as a moderator in the pyroptosis process of cancer cells. However, relevant explorations about lncRNAs and pyroptosis are still insufficient in PAAD. Therefore, our research is designed to make a comprehensive analysis of the potential values of pyroptosis-related lncRNAs in PAAD.Methods: By integrating the RNA-sequencing, somatic mutation, and copy number variation (CNV) datasets, as well as the clinicopathological features, we established and validated a risk signature based on pyroptosis-related lncRNAs, and comprehensively analyzed its clinical significance and the potential connection with the tumor immune microenvironment (TIME).Consequences: The genetic variation landscape displayed that the somatic mutations were rare while CNV changes were general and mainly concentrated on copy number amplification of these 52 pyroptosis-related genes. Subsequently, a risk signature consisting of 10 lncRNAs (TRAF3IP2-AS1, LINC00519, LINC01133, LINC02251, AC005332.6, AL590787.1, AC090114.2, TRPC7-AS1, MIR223HG, and MIR3142HG) was constructed and patients were divided into different subgroups according to the median risk score; patients with high-risk scores presented worse outcomes compared to those with low-risk scores in the training, testing, and entire cohorts. Furthermore, patients at low-risk scores possessed a higher infiltration abundance of immune cells compared with high-risk patients, which was consistent with the expression levels of lncRNAs between the high/low-risk groups. Drug sensitivity analysis showed that low-risk scores were related to anti-cancer agents like AICAR and Axitinib, whereas high-risk scores were connected with certain drugs such as AUY922. These results demonstrated that our risk signature could be used for prognosis prediction; additionally, it was also related to the TIME that might act as a potential indicator to instruct immunotherapeutic strategies.Conclusion: This work explored the significance of the risk model constructed by pyroptosis-related lncRNAs in prognosis prediction and its internal link with the immune microenvironment of PAAD. The results are expected to assist in the diagnosis, prognostic assessment, and management of patients with PAAD.
引用
收藏
页数:17
相关论文
共 50 条
  • [31] Values of a novel pyroptosis-related genetic signature in predicting outcome and immune status of pancreatic ductal adenocarcinoma
    Xu, Xiang
    Liang, Jia-Hua
    Li, Jian-Hui
    Xu, Qiong-Cong
    Yin, Xiao-Yu
    GASTROENTEROLOGY REPORT, 2022, 10
  • [32] Stemness related lncRNAs signature for the prognosis and tumor immune microenvironment of ccRCC patients
    Zhang, Mengjiao
    Zhang, Jiqiang
    Liang, Xuemei
    Zhang, Ming
    BMC MEDICAL GENOMICS, 2024, 17 (01)
  • [33] Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer
    Wang, Yi
    Zhu, Gui-Qi
    Tian, Di
    Zhou, Chang-Wu
    Li, Na
    Feng, Ying
    Zeng, Meng-Su
    BMC CANCER, 2022, 22 (01)
  • [34] Construction of a Pyroptosis-Related Signature for Prognostic Prediction and Characterization of Immune Microenvironment in Acute Myelogenous Leukemia
    Liu, Songyang
    Luo, Dongmei
    Luo, Jie
    Liang, Hanyin
    Zhi, Yunfei
    Wang, Dong
    Xu, Na
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2022, 15 : 2913 - 2927
  • [35] Novel pyroptosis-related lncRNAs and ceRNAs predict osteosarcoma prognosis and indicate immune microenvironment signatures
    Yang, Mingyi
    Zheng, Haishi
    Su, Yani
    Xu, Ke
    Yuan, Qiling
    Cai, Yongsong
    Aihaiti, Yirixiati
    Xu, Peng
    HELIYON, 2023, 9 (11)
  • [36] A Pyroptosis-Related Gene Panel for Predicting the Prognosis and Immune Microenvironment of Cervical Cancer
    Hu, Haoran
    Yang, Meiqin
    Dong, Wei
    Yin, Bo
    Ding, Jianyi
    Huang, Baoyou
    Zheng, Qingliang
    Li, Fang
    Han, Lingfei
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [37] Identification of a pyroptosis-related prognosis gene signature and its relationship with an immune microenvironment in gliomas
    Xiao, Shengying
    Yan, Zhiguang
    Zeng, Furen
    Lu, Yichen
    Qiu, Jun
    Zhu, Xiaodong
    MEDICINE, 2022, 101 (28) : E29391
  • [38] A pyroptosis-related gene signature predicting survival and tumor immune microenvironment in breast cancer and validation
    Gong, Mingkai
    Liu, Xiangping
    Zhao, Xian
    Wang, Haibo
    BMC CANCER, 2022, 22 (01)
  • [39] A pyroptosis-related gene signature that predicts immune infiltration and prognosis in colon cancer
    Wu, Mingjian
    Hao, Shuai
    Wang, Xiaoxiang
    Su, Shuguang
    Du, Siyuan
    Zhou, Sitong
    Yang, Ronghua
    Du, Hanpeng
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [40] Pyroptosis-Related LncRNA Signature Predicts Prognosis and Is Associated With Immune Infiltration in Hepatocellular Carcinoma
    Liu, Ze-Kun
    Wu, Ke-Fei
    Zhang, Ren-Yu
    Kong, Ling-Min
    Shang, Run-Ze
    Lv, Jian-Jun
    Li, Can
    Lu, Meng
    Yong, Yu-Le
    Zhang, Cong
    Zheng, Nai-Shan
    Li, Yan-Hong
    Chen, Zhi-Nan
    Bian, Huijie
    Wei, Ding
    FRONTIERS IN ONCOLOGY, 2022, 12